Glucose Tolerance and the Risk Factors for Transmission in Japanese SARS-CoV-2/WA-1/2020 Epicenter: A Retrospective Study
Manabu Saito,Hiroshi Uchino,Yoko Iwata,Ayako Fuchigami,Genki Sato,Fukumi Yoshikawa,Masahiko Miyagi,Taito Miyazaki,Yoshihisa Urita,Kotaro Aoki,Yoshikazu Ishii,Kazuhiro Tateda,Takahisa Hirose
DOI: https://doi.org/10.2147/dmso.s450230
2024-06-21
Diabetes Metabolic Syndrome and Obesity Targets and Therapy
Abstract:Manabu Saito, 1, &ast Hiroshi Uchino, 1, &ast Yoko Iwata, 1 Ayako Fuchigami, 1 Genki Sato, 1 Fukumi Yoshikawa, 1 Masahiko Miyagi, 1 Taito Miyazaki, 2 Yoshihisa Urita, 2 Kotaro Aoki, 3 Yoshikazu Ishii, 3 Kazuhiro Tateda, 3 Takahisa Hirose 1 1 Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Graduate School of Medicine, Tokyo, Japan; 2 Department of General Medicine and Emergency Care, Toho University School of Medicine, Tokyo, Japan; 3 Department of Microbiology and Infectious Diseases, Toho University School of Medicine, Tokyo, Japan &astThese authors contributed equally to this work Correspondence: Hiroshi Uchino, Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Toho University Graduate School of Medicine, 6-11-1 Omori-nishi, Ota-ku, Tokyo, 143-8541, Japan, Tel +81-3-3762-4151, Fax +81-3-3765-6488, Email Purpose: The severe pathogenic ancient-type COVID-19, SARS-CoV-2/WA-1/2020 was the predominant gene variant in early 2020 in Japan, however, its transmissibility was uncertain. The period before the public commenced using any personal protective equipment (PPE) was evaluating to describe the transmissibility of the SARS-CoV-2/WA-1/2020. We analyzed the secondary attack rate (SAR) among close contacts and the risk factor for SAR. Methods: This retrospective cohort study included a total of 539 patients who were anticipated for the SARS-CoV-2/WA-1/2020 infection at Toho University Medical Center Omori Hospital from February to May 2020. We selected 54 patients with 1) exclude other pathogens infection, 2) include "Three Cs" condition: crowded places between distance 15min with a person tested positive for SARS-CoV-2/WA-1/2020 without PPE. We evaluated alternative infection risks: the body mass index (BMI) and diabetes (DM) status (non-DM, pre-DM, and DM) as demographic determinants of transmissibility and infectivity of SARS-CoV2/WA-1/2020 cases during the incubation period. Results: The calculated SAR was 79.3%. BMI was significantly associated with the PCR positivity rate, which was significant in the univariate (CI 95%, 1.02– 1.51; P = 0.03) and multivariate (CI 95%, 1.02– 1.60; P = 0.03) analyses. Comparing the different BMI groups, the highest BMI group (25.5− 35.8 kg/m 2 ) had an elevated risk of SAR compared to the lowest BMI group (14.0– 22.8 kg/m 2 ), with an odds ratio of 1.41 (95% CI, 1.02– 1.59; P = 0.03). There were no significant differences in the risk of SAR among different DM statuses. Conclusion: The transmissibility of SARS-CoV2/WA-1/2020 was high (79.3%) among household members without PPE who had "Three Cs" exposure. Although pre-DM and established DM did not confer a risk for transmissibility, higher BMI was associated with an increased risk of SAR. Trial Registration: UMIN Clinical Trials Registry, UMIN0000 50905. Keywords: obesity, pre-diabetes, SARS-CoV-2 transmission Since the two studies that identified a novel coronavirus-associated infectious disease, 1,2 there have been reports of single-center experiences involving a small number of patients in China. Subsequently, multicenter experiences from various regions worldwide, starting from Asia, 3–5 followed by Europe and the USA, mirrored the spread of the pandemic's epicenter. Since early 2020, many countries have experienced the coronavirus disease (COVID-19) pandemic, with underreported cases of severe respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and related deaths. 6 Throughout 2020 and 2021, the pandemic has been extensively studied, examining various epidemiological factors, including age, sex, ethnicity, and comorbidities in the population. 7,8 Previous studies have consistently identified older age, male sex, obesity, hypertension, diabetes mellitus (DM), cardiovascular disease, chronic lung disease, renal disease, and cerebrovascular disease as risk factors for COVID-19 mortality. 9–12 Mild hyperglycemia (>7.0 mM [126 mg/dl]) upon hospital admission, without a known diagnosis of DM, has also been associated with poor outcomes and increased mortality. 13 Also, observational study which reported the different COVID-19 outcomes between BMI and the state of obesity, adiposity related metabolic dysfunctions are associated with enhanced inflammation and metabolic imbalance. These are leading to pro-inflammatory state and associated with worse viral infection outcome -Abstract Truncated-
endocrinology & metabolism